Ionis Pharmaceuticals, Inc. · NASDAQ:IONS
Bennett C Frank reported 1 trade in Ionis Pharmaceuticals, Inc. shares (Form 4)
Traded Aug 31, 2026 · Filed Sep 2, 2026
On Aug 31, 2026, Bennett C Frank (EVP, Chief Scientific Officer) reported 1 trade in Ionis Pharmaceuticals, Inc. shares at US$51.31 for US$5,644, leaving 60,128 shares. Filed Sep 2, 2026 (Form 4).
- Shares
- 110 shares
- Price
- US$51.31
- Value
- US$5,644
- Holding after
- 60,128 shares
- Trading plan
- No
- Role
- EVP, Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | Common Stock | Other | 110 | US$51.31 | 60,128 | Direct |
Source
Related
- Ionis Pharmaceuticals, Inc.
- Bennett C Frank
- Ionis Pharmaceuticals, Inc. shareholders
- Form 4 · Bennett C Frank · Jul 9, 2026
- Form 4 · Devers Shannon L. · Oct 19, 2026
- Form 4 · Swayze Eric · Oct 19, 2026
- Form 4 · O'Neil Patrick R. · Sep 2, 2026
- Form 4 · Monia Brett P · Sep 2, 2026
- Form 4 · Birchler Brian · Sep 2, 2026